https://orcid.org/0000-0003-3607-9788
Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Meghan E Pauley, Cari Berget, Laurel H Messer & Gregory P Forlenza. (2021) Barriers to Uptake of Insulin Technologies and Novel Solutions. Medical Devices: Evidence and Research 14, pages 339-354.
Read now
Read now
Jennifer McVean & Joshua Miller. (2021) MiniMedTM780G Insulin pump system with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy. Expert Review of Medical Devices 18:6, pages 499-504.
Read now
Read now
Articles from other publishers (36)
Quoc Dat Do, Aneta Hásková, Lucie Radovnická, Judita Konečná, Eva Horová, Christopher G. Parkin, George Grunberger, Martin Prázný & Jan Šoupal. (2023) Comparison of Control‐IQ and open‐source AndroidAPS automated insulin delivery systems in adults with type 1 diabetes: The CODIAC study. Diabetes, Obesity and Metabolism 26:1, pages 78-84.
Crossref
Crossref
Muhammad A. Cheema, Pallavi Patil, Salman I. Siddiqui, Pierluigi Salvo Rossi, Øyvind Stavdahl & Anders Lyngvi Fougner. (2023) Data-Driven Classifiers for Early Meal Detection Using ECG. IEEE Sensors Letters 7:9, pages 1-4.
Crossref
Crossref
Fatima Z. Radi, Noureddine Bencheikh, Mohamed Bouhrim, Asmaa Saleh, Omkulthom Al kamaly, Mohammad K. Parvez, Amine Elbouzidi, Mohamed Bnouham & Touriya Zair. (2023)
Phytochemical Analysis, Antioxidant, and Antihyperglycemic Activities of
Crataegus monogyna
Jacq Aqueous Extract
. Natural Product Communications 18:8.
Crossref
Crossref
Beate Bittner, Manuel Sánchez-Félix, Dennis Lee, Athanas Koynov, Joshua Horvath, Felix Schumacher & Simon Matoori. (2023) Drug delivery breakthrough technologies – A perspective on clinical and societal impact. Journal of Controlled Release 360, pages 335-343.
Crossref
Crossref
Joseph E BiskupiakMafalda RamosCarol J LevyGreg ForlenzaColin HopleyJennifer BoydDan SwiftMark LamotteDiana I Brixner. (2023) Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States. Journal of Managed Care & Specialty Pharmacy 29:7, pages 807-817.
Crossref
Crossref
Amisha S. Raikar, Pramod Kumar, Gokuldas (Vedant) S. Raikar & Sandesh N. Somnache. (2023) Advances and Challenges in IoT-Based Smart Drug Delivery Systems: A Comprehensive Review. Applied System Innovation 6:4, pages 62.
Crossref
Crossref
Sofia Peacock, Isolda Frizelle & Sufyan Hussain. (2023) A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes Therapy 14:5, pages 839-855.
Crossref
Crossref
Abishek Chandrasekhar, Divya Saini & Radhakant Padhi. (2023) An artificial pancreas system in android phones: A dual app architecture. Pervasive and Mobile Computing 91, pages 101767.
Crossref
Crossref
Silvia Del Giorno, Federico D’Antoni, Vincenzo Piemonte & Mario Merone. (2023) A New Glycemic closed-loop control based on Dyna-Q for Type-1-Diabetes. Biomedical Signal Processing and Control 81, pages 104492.
Crossref
Crossref
Wenping Liu, Ting Chen, Bingjin Liang, Yanran Wang & Haoyu Jin. (2023) In-silico evaluation of an artificial pancreas achieving automatic glycemic control in patients with type 1 diabetes. Frontiers in Endocrinology 14.
Crossref
Crossref
Giovanni Annuzzi, Andrea Apicella, Pasquale Arpaia, Lutgarda Bozzetto, Sabatina Criscuolo, Egidio De Benedetto, Marisa Pesola, Roberto Prevete & Ersilia Vallefuoco. (2023) Impact of Nutritional Factors in Blood Glucose Prediction in Type 1 Diabetes Through Machine Learning. IEEE Access 11, pages 17104-17115.
Crossref
Crossref
Melissa N. Pelkey, Mary E. Boyle, Ashley Long, Janna C. Castro, Curtiss B. Cook & Bithika Thompson. (2023) Hybrid Closed-Loop Insulin Pump Technology Can Be Safely Used in the Inpatient Setting. Endocrine Practice 29:1, pages 24-28.
Crossref
Crossref
Abdulhalim M. Almurashi, Erika Rodriguez & Satish K. Garg. (2023) Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases. Journal of the Indian Institute of Science 103:1, pages 205-230.
Crossref
Crossref
Léonie Makuété Notemi, Lamia Amoura, Fatéma Fall Mostaine, Laurent Meyer, Dominique Paris, Samy Talha, Julien Pottecher & Laurence Kessler. (2022) Long-term efficacy of sensor-augmented pump therapy (Minimed 640G system) combined with a telemedicine follow-up in patients with type 1 diabetes: A real life study. Journal of Clinical & Translational Endocrinology 30, pages 100306.
Crossref
Crossref
Doni Dermawan & Muhammad Abiyyu Kenichi Purbayanto. (2022) An overview of advancements in closed-loop artificial pancreas system. Heliyon 8:11, pages e11648.
Crossref
Crossref
Keren Zhou & Diana Isaacs. (2022) Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes. Current Cardiology Reports 24:9, pages 1159-1167.
Crossref
Crossref
Chirath Hettiarachchi, Nicolo Malagutti, Christopher Nolan, Eleni Daskalaki & Hanna Suominen. (2022) A Reinforcement Learning Based System for Blood Glucose Control without Carbohydrate Estimation in Type 1 Diabetes: In Silico Validation. A Reinforcement Learning Based System for Blood Glucose Control without Carbohydrate Estimation in Type 1 Diabetes: In Silico Validation.
Cari Berget, Jennifer L. Sherr, Daniel J. DeSalvo, Ryan S. Kingman, Sheri L. Stone, Sue A. Brown, Alex Nguyen, Leslie Barrett, Trang T. Ly & Gregory P. Forlenza. (2022) Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes. Clinical Diabetes 40:2, pages 168-184.
Crossref
Crossref
Gregory P. Forlenza, Tim Vigers, Cari BergetLaurel H. MesserRayhan A. Lal, Marina BasinaDavid M. MaahsKorey Hood, Bruce BuckinghamDarrell M. WilsonR. Paul Wadwa, Kimberly A. DriscollLaura Pyle. (2022) Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study. Diabetes Technology & Therapeutics 24:3, pages 157-166.
Crossref
Crossref
Aideen Daly, Sara Hartnell, Charlotte K. Boughton & Mark Evans. (2021) Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series. Journal of Diabetes Science and Technology 15:6, pages 1216-1223.
Crossref
Crossref
Aleix Beneyto, Vicenç Puig, B. Wayne Bequette & Josep Vehi. (2021) A Hybrid Automata Approach for Monitoring the Patient in the Loop in Artificial Pancreas Systems. Sensors 21:21, pages 7117.
Crossref
Crossref
Ouijdane Benayad, Mohamed Bouhrim, Salima Tiji, Loubna Kharchoufa, Mohamed Addi, Samantha Drouet, Christophe Hano, Jose Manuel Lorenzo, Hasnae Bendaha, Mohamed Bnouham & Mostafa Mimouni. (2021) Phytochemical Profile, α-Glucosidase, and α-Amylase Inhibition Potential and Toxicity Evaluation of Extracts from Citrus aurantium (L) Peel, a Valuable By-Product from Northeastern Morocco. Biomolecules 11:11, pages 1555.
Crossref
Crossref
V. V. Klimontov, V. B. Berikov & O. V. Saik. (2021) Artificial intelligence in diabetology. Diabetes mellitus 24:2, pages 156-166.
Crossref
Crossref
Simon Lebech Cichosz, Morten Hasselstrøm Jensen & Ole Hejlesen. (2021) Short-term prediction of future continuous glucose monitoring readings in type 1 diabetes: Development and validation of a neural network regression model. International Journal of Medical Informatics 151, pages 104472.
Crossref
Crossref
Élisa Maillard, Séverine Sigrist, Laurent Meyer & Nathalie Jeandidier. (2021) Insulines intelligentes et pancréas bioartificiel dans le DT1 : acteurs de demain, vraiment?. Médecine des Maladies Métaboliques 15:3, pages 3S65-3S75.
Crossref
Crossref
Chiara Toffanin, Lalo Magni & Claudio Cobelli. (2021)
Artificial Pancreas:
In Silico
Study Shows No Need of Meal Announcement and Improved Time in Range of Glucose With Intraperitoneal vs. Subcutaneous Insulin Delivery
. IEEE Transactions on Medical Robotics and Bionics 3:2, pages 306-314.
Crossref
Crossref
Daniela Bruttomesso, Federico Boscari, Giuseppe Lepore, Giulia Noaro, Giacomo Cappon, Angela Girelli, Lutgarda Bozzetto, Andrea Tumminia, Giorgio Grassi, Giovanni Sparacino, Luigi Laviola & Andrea Facchinetti. (2021) A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life. Diabetes Therapy 12:5, pages 1313-1324.
Crossref
Crossref
Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding & Sepideh Afshar. (2021) Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases. International Journal of Molecular Sciences 22:6, pages 2805.
Crossref
Crossref
Guiling Yu, Yuanhuan Yu & Haifeng Ye. 2021. Mammalian Cell Engineering. Mammalian Cell Engineering
141
158
.
Amparo Güemes Gonzalez, Ralph Etienne-Cummings & Pantelis Georgiou. (2020) Closed-loop bioelectronic medicine for diabetes management. Bioelectronic Medicine 6:1.
Crossref
Crossref
Francesca Corduas, Elena Mancuso & Dimitrios A. Lamprou. (2020) Long-acting implantable devices for the prevention and personalised treatment of infectious, inflammatory and chronic diseases. Journal of Drug Delivery Science and Technology 60, pages 101952.
Crossref
Crossref
A. Quintal, V. Messier, R. Rabasa‐Lhoret & E. Racine. (2020) A qualitative study exploring the expectations of people living with type 1 diabetes regarding prospective use of a hybrid closed‐loop system. Diabetic Medicine 37:11, pages 1832-1840.
Crossref
Crossref
Mark ChristiansenAmy BarteeAmy LalondeRichard E. JonesMichelle KatzHoward WolpertRonald Brazg. (2020) Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies. Diabetes Technology & Therapeutics.
Crossref
Crossref
Marc D. BretonLauren G. KanapkaRoy W. BeckLaya EkhlaspourGregory P. ForlenzaEda CengizMelissa SchoelwerKatrina J. RuedyEmily JostLori CarriaEmma EmoryLiana J. HsuMary OliveriCraig C. KollmanBetsy B. DokkenStuart A. WeinzimerMark D. DeBoerBruce A. BuckinghamDaniel CherñavvskyR. Paul Wadwa. (2020) A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. New England Journal of Medicine 383:9, pages 836-845.
Crossref
Crossref
Erin C Cobry, Cari Berget, Laurel H Messer & Gregory P Forlenza. (2020)
Review of the Omnipod
®
5 Automated Glucose Control System Powered by Horizon™ for the treatment of Type 1 diabetes
. Therapeutic Delivery 11:8, pages 507-519.
Crossref
Crossref
J. Lawton, B. Kimbell, D. Rankin, N. L. Ashcroft, L. Varghese, J. M. Allen, C. K. Boughton, F. Campbell, T. Randell, R. E. J. Besser, N. Trevelyan & R. Hovorka. (2020) Health professionals' views about who would benefit from using a closed‐loop system: a qualitative study. Diabetic Medicine 37:6, pages 1030-1037.
Crossref
Crossref